ALB and cancer: Surface modification of NPs with biomacromolecules, typically proteins, has been extensively studied, with wheat germ agglutinin and human serum albumin (HSA) the most commonly used in anti-cancer NPs, proving reduced initial burst release of loaded drugs [265,266].